Chime Biologics Congratulates Hope Medicine Inc. on Successful Dosing of First Patient in Phase III Clinical Trial for Endometriosis in China
Article Date
March 27, 2026
This article is featured on another website.
Go to article
May 11, 2026
Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026
May 11, 2026
Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…
May 26, 2026
Closing the Cross-Border Gap for Global Trials
Closing the Cross-Border Gap: Why Modern Global CROs Must Link Regulatory Strategy to Multi-Region Execution.…